Corporate News

HDI and Hannover Re roll out booster shots

  • Launch date of 13 December in Hannover
  • Further locations to follow starting in January

On Monday, 13 December vaccinations will start up again at HDI and Hannover Re. The insurers belonging to the Talanx Group will begin by offering booster shots to their staff in Hannover. Daily vaccination slots are planned right through to 23 December and for the entire month of January. At HDI's second main location in Cologne booster shots are expected to roll out from 10 or 12 January onwards. As for the other locations in Germany, the various companies also intend to offer boosters to their employees in the very near future.


Members of staff can receive their booster five months or more after completing the basic immunisation programme of two shots. Those over the age of 30 will likely receive Moderna's mRNA vaccine, while younger employees will be given BioNTech. Individuals who received the Johnson & Johnson vaccine as their first dose must wait a minimum of four weeks before they can boost their immunity with an additional shot of mRNA vaccine.

Jens Warkentin, Personnel Director of the HDI Group, comments: "In order to protect our employees to the best of our ability and help them negotiate the pandemic as safely as possible, we decided to undertake this additional vaccination campaign. Ultimately, a very high level of vaccination is the only way out of this crisis."

Back in the summer of 2021 HDI and Hannover Re had made vaccines available to their employees across Germany with very good results. Altogether, some 3,000 first and second shots have already been administered in this context. And even now members of the workforce who have not yet been vaccinated have another chance to get their protective jab in-house – absolutely in the spirit of the Group's purpose "Together we take care of the unexpected and foster entrepreneurship".

For media enquiries please contact:

Andreas Krosta
Tel.: +49 511-3747-2020

Andreas Ahrenbeck
Tel.: +49 511 645-4746

Hannover Re
Oliver Süß
Tel.: +49 511-5604-1502


This news release contains forward-looking statements which are based on certain assumptions, expectations and opinions of the Talanx AG management. These statements are, therefore, subject to certain known or unknown risks and uncertainties. A variety of factors, many of which are beyond Talanx AG’s control, affect Talanx AG’s business activities, business strategy, results, performance and achievements. Should one or more of these factors or risks or uncertainties materialise, actual results, performance or achievements of Talanx AG may vary materially from those expressed or implied in the relevant forward-looking statement. Talanx AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does Talanx AG accept any responsibility for the actual occurrence of the forecasted developments. Talanx AG neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.